Perforin delivers granzymes to induce target-cell apoptosis. At high concentrations, perforin multimerizes in the plasma membrane to form pores. However, whether granzymes enter target cells via membrane pores is uncertain. Here we find that perforin at physiologically relevant concentrations and during cellmediated lysis creates pores in the target-cell membrane, transiently allowing Ca 2+ and small dyes into the cell. The Ca 2+ flux triggers a wounded membranerepair response in which internal vesicles, including lysosomes and endosomes, donate their membranes to reseal the damaged membrane. Perforin also triggers the rapid endocytosis of granzymes into large EEA-1-staining vesicles. The restoration of target-cell membrane integrity by triggering the repair response is necessary for target cells subjected to cytotoxic T lymphocyte attack to avoid necrosis and undergo the slower process of programmed cell death. Thus, the target cell actively participates in determining its own fate during cell-mediated death.
Introduction

Perforin (PFN) plays an essential role in the granule exocytosis pathway of target-cell apoptosis, the main way cytotoxic T cells (CTL) and natural killer (NK) cells eliminate virus-infected cells and tumors. Apoptotic target-cell death is triggered by release of cytotoxic granule contents into the immunological synapse formed by CTL binding to its target cell
). Cytotoxic granules contain PFN and a group of serine proteases called granzymes (Gzm) in a proteoglycan matrix (Lieberman, 2003) . PFN delivers Gzms into the target-cell cytosol. Because multiple Gzms can independently trigger target-cell apoptosis, targeted disruption of any one Gzm gene in mice only modestly affects immune protection. However, there is only one known delivery molecule. Consequently, mice deficient in PFN are profoundly immunodeficient and are unable to protect themselves against viral infection and tumors (Kagi et al., 1994) . Humans with familial hemophagocytic lymphohistiocytosis due to PFN gene mutations also have compromised antiviral immunity *Correspondence: lieberman@cbr.med.harvard.edu (Stepp et al., 1999) . Although PFN was identified almost 20 years ago and cloned shortly thereafter, the molecular and cellular basis for PFN activity remains uncertain (Catalfamo and Henkart, 2003) .
At low "sublytic" concentrations, PFN delivers Gzms to induce apoptosis but causes little cell death on its own. At higher "lytic" concentrations, PFN induces necrotic death, but not apoptosis, independently of granzymes. Apoptosis, which requires activating a series of endogenous pathways, occurs slowly over more than an hour, while necrotic death via PFN occurs within minutes and preempts the ability to undergo programmed cell death. PFN-induced necrosis is thought to be due to loss of plasma membrane integrity. Since CTL and NK cells kill target cells by apoptosis (Russell et al., 1980) , sublytic concentrations are thought to be physiologically relevant. The sublytic PFN concentration that induces 5%-15% necrosis delivers Gzms but varies between target cells and preparations and must be carefully titrated for each experiment (Shi et al., 1992) . . Although apoptosis is not induced until PFN is added, initial experiments suggested that apoptosis could be triggered when PFN is added to cells that had previously endocytosed GzmB (Froelich et al., 1996 ; Pinkoski et al., 1998). This result led to a revised model in which PFN acts to release Gzms from endosomes (Froelich et al., 1996) . This idea was supported by finding that adenovirus and bacterial pore-forming proteins, such as streptolysin, that cause endosomal disruption can substitute for PFN to introduce Gzms into target cells (Browne et al., 1999; Froelich et al., 1996; Pinkoski et al., 1998) .
PFN shares homology with terminal complement components. Because, like complement, PFN multimerizes in membranes to form pores, PFN was originally hypothesized to deliver Gzms to target cells through plasma membrane pores (Masson and
How extracellular PFN acting on the plasma membrane could target Gzm release from membrane bound intracellular vesicles was unclear. This caused us to reexamine whether adding PFN to cells, which had previously endocytosed GzmB, could trigger apoptosis. Because the Gzms are highly basic (pIs w9-11) and the plasma membrane negatively charged, GzmB remains bound to the surface of washed cells, unless cells are washed with high-ionic-strength buffers ( We find that sublytic PFN triggers a rapid damaged membrane response, which restores plasma membrane integrity to allow codelivered Gzms to induce the slow process of apoptosis. When the repair response is inhibited, cells treated with GzmB and sublytic PFN are more likely to die by necrosis than by apoptosis. GzmB and sublytic PFN treatment is only a model for what happens during granule-mediated cell death by killer lymphocytes. Therefore, we were careful to validate our results using CTL effector cells. Target cells subjected to CTL attack behave like targets treated with GzmB and sublytic PFN. They experience a transient Ca 2+ flux and respond to repair the damaged membrane by mobilizing intracellular vesicles. Interfering with the repair response also shifts the balance of target-cell death from apoptosis toward necrosis during CTL attack.
Results
A Narrow Window for Perforin Delivery of Granzymes to Induce Apoptosis U937 cells were treated with native PFN, purified from rat NK cells as described (Shi et al., 2000) . At PFN concentrations above 250 ng/ml, a substantial proportion of U937 cells take up trypan blue, but their nuclei do not show morphological features of apoptosis ( Figure  1A , data not shown). If GzmB is added with high concentrations of PFN, cells still die mostly by necrosis. This PFN concentration is termed lytic. If the PFN concentration is reduced by half to 125 ng/ml, only 9% of cells take up trypan blue; but if GzmB is added simultaneously, 82% of cells become apoptotic. This PFN concentration, which delivers Gzms but does not cause cell death on its own, is called sublytic. If the PFN concentration is again reduced by half, PFN no longer effectively delivers Gzms. Similar results are obtained with other cells, including K562, HeLa, COS, and B-LCL.
The sublytic concentration is between 50 and 500 ng/ ml, but the concentration varies from cell to cell and perforin preparation. There is only a 3-to 4-fold variation between a PFN concentration too low to deliver Gzms and a lytic concentration that induces necrosis, with the sublytic concentration somewhere in between. Therefore, we have independently determined the sublytic concentration for each experiment as that inducing 5%-15% trypan blue inclusion in the absence of added Gzms. By contrast to the narrow window for PFN sublytic activity, the dose-response curve for GzmBinduced apoptosis at a fixed sublytic PFN concentration increases steadily from no activity at w0.25 g/ml to reach a plateau at w2 g/ml (data not shown).
Perforin Perturbs the Plasma Membrane
Within seconds of adding sublytic PFN to HeLa cells, the cell membrane is perturbed with a bubbling appearance caused by the formation of rounded membrane protuberances that enlarge and fuse over the first few minutes (see Movie S1 in the Supplemental Data available online with this article). Blebs of up to 3 m diameter form focally along the outer membrane. Some blebs resolve over the 10 min of observation and appear to be taken up into the cell. In some cells, tubulations that connect neighboring cells appear. To visualize the membrane better, HeLa cells were labeled with the vital membrane dye DiI and treated with PFN in the presence of the cell impermeant nuclear dye Sytox green ( Figure 1B) . Sytox green nuclear staining correlates with trypan blue uptake (data not shown) and indicates loss of membrane integrity and necrotic death. Using a sublytic PFN concentration, DiI-staining membrane blebs can be readily seen, but the nuclear dye is largely excluded. A three-dimensional reconstruction of the PFNtreated cell shows multiple membrane-delimited blebs. One of these blebs contains Sytox green, suggesting that the membrane may have been temporarily damaged to allow the dye in, but then resealed (see below; Movie S2). Some of the blebs detach from the cell (Figure 1C) . Interestingly, after PFN treatment, DiI also appears to stain intracellular membranes, consistent with a previous report of plasma membrane exchange induced by PFN (Kawasaki et al., 2000) . When a lytic concentration of PFN is used, blebs still form, but the membrane barrier is not preserved, allowing Sytox green into the cell. (Figure 2A ). At 320 ng/ml, a sublytic concentration at which 9% of cells incorporate seminate into the cytosol in most cells. Because the amount of trypan blue taken up into blebs is so small that it is difficult to visualize by microscopy, we used more sensitive fluorescent dyes (FITC-dextran, PI) to also look at uptake of small dyes into U937 cells treated with sublytic PFN by fluorescence microscopy ( Figures  3C and 3D ) and into cells treated with rat NK cell granules, a more physiologically relevant source of PFN, by flow cytometry ( Figure 3E ). In cells incubated with medium, few cells take up PI and the background mean fluorescence intensity (MFI) is w10. However, when cells are treated with granules, the number of cells that do not stain above background for PI is reduced in a dose-dependent manner and two new populations of cells are now observed-a dimly staining (MFI w100) and a brightly staining (MFI w1000) population. At a lytic concentration of granules, the dim population disappears and the brightly staining cells predominate. We interpret these data to mean that the dimly staining cells have taken up the dye and contained it within blebs, while in the brightly staining cells, the membrane damage has not been controlled and dye continues to influx. Because Ca 2+ ions diffuse much more rapidly than small dyes like trypan blue or PI, Ca 2+ fluxes occur throughout the cytosol (Figure 2) , while negligible amounts of dye get into the cytosol before the membrane-limited blebs form. Because PI fluorescence is difficult to detect unless the dye is bound to nucleic acids, the detection of PI in the blebs suggests the possibility that cytosolic RNA might be in the blebs. This is consistent with an earlier, perhaps surprising, report that the apoptotic blebs produced after PFN and GzmA treatment contain RNA (Beresford et al., 1999 Figure 4B ). Diffuse uptake of small dyes, such as PI or trypan blue, indicates a sustained breach in plasma membrane integrity that correlates with necrotic death. At sublytic concentrations of 0.2-0.4 g/ml, cells acquire cell-surface Lamp-1 expression, identified by staining without permeabilization. However, bright PI staining is seen in <10% of cells, compared to background. Other internal proteins, such as the ER-associated protein calreticulin, remain intracellular and are not detected on the cell surface. Lamp-1 can be seen in discrete patches on the cell membrane, particularly on the membrane overlying the membrane blebs ( Figure  4C ). This likely represents discrete fusion events of lysosomes to the plasma membrane. Blebs may form because the donated membrane causes focal increases in membrane surface area.
Sublytic Perforin Triggers a Transient
Since a Ca 2+ influx is required to trigger fusion of lysosomal membranes to the plasma membrane, we determined whether Lamp-1 is externalized in cells preloaded with the cell-permeant methyl ester BAPTA-AM, which is converted within cells to the Ca 2+ chelator (Figures 5A and 5B) . In fact, BAPTA-loaded HeLa cells are more susceptible to PFNmediated necrosis. While background PI incorporation in the absence of PFN was slightly different in BAPTAloaded cells (control, 5.8% ± 0.4% versus BAPTA-AMloaded, 7.5% ± 0.1%), at a sublytic concentration of PFN (0.2 g/ml), there was almost twice as much cell death (control, 13.3% ± 3.4% versus BAPTA-AMloaded, 22.6% ± 2.1%, p < 0.02). At a lytic concentration of PFN (0.4 g/ml), there was also significantly more cell death (control, 29.7% ± 3.0% versus BAPTA-AM-loaded, 44.9% ± 6.7%, p < 0.03). At this higher concentration, the membrane-repair response could mitigate against PFN-mediated necrosis in some cells but could not patch up the damage in many cells.
A distinct dimly PI-staining population was not detected by flow cytometry in treated HeLa cells, as was seen in U937 cells in Figure 3D . Nonetheless, microscopy showed trypan blue-containing blebs in HeLa cells ( Figure 3B ). To look at the effect of Ca 2+ chelation on U937 cells in which we could distinguish PI dim cells, we analyzed PI incorporation in BAPTA-loaded and control cells treated with RNK granules, a more physiologically relevant reagent than purified PFN. BAPTA loading slightly increased the numbers of PI dim or PI bright cells in the absence of granules. After granule treatment, there was no difference in PI − cells, but blocking membrane repair via Ca 2+ chelation reduced the proportion of PI dim cells from 37% ± 2% to 21% ± 1% (p < 0.001) and increased the necrotic PI bright cells from 56% ± 2% to 72% ± 2% (p < 0.001). Therefore, wound healing allows the cells to avoid necrosis.
Blocking the Membrane-Repair Response Reduces PFN-and GzmB-Mediated Apoptosis
Although inhibiting membrane repair enhanced cell death, the opposite effect was observed when cells treated with sublytic PFN and GzmB were assayed for apoptosis by TUNEL staining (Figures 5D and 5E ). Although there was a slight, but significant, increase in TUNEL staining of BAPTA-AM-loaded cells compared to control cells following treatment with sublytic PFN alone (control, 6.8% ± 0.3% versus BAPTA, 10.8% ± 0.9%, p < 0.002), there was dramatically less TUNEL staining in BAPTA-treated cells than control cells exposed to GzmB and the same amount of PFN (control, 47.5% ± 4.5% versus BAPTA, 14.9% ± 2%, p < 0.001). Because apoptosis is a slow process that requires w2 hr to induce DNA damage (Shi et al., 2005) , TUNEL staining was performed 2 hr after adding PFN, while necrosis was measured after 30 min. (It should be noted that during the additional incubation, some necrotic cells have already disintegrated and are not counted in the analysis.) We interpret these results to mean that if cells cannot repair the membrane damage caused by PFN, they die immediately by necrosis because the plasma membrane barrier has been irreparably breached, which precludes triggering the slower pathway of apoptosis. Figure 6D, data not shown) . However, although it triggers cellular wound healing, ionomycin does not enhance GzmB-488 uptake by U937 cells, even at the highest concentrations that do not cause cell death (Figures 6C and 6D) . Therefore, PFN likely needs to do more than trigger a Ca 2+ flux and wound healing to cause rapid GzmB endocytosis. valin A-coated HeLa cells are subjected to CTL attack, we also detect large EEA-1-staining membrane-proximal vesicles that resemble the EEA-1-staining GzmBcontaining vesicles seen during PFN loading of GzmB in Figure 6A (Figure 7D ). Moreover, just as inhibiting wound healing in PFN or granule-loading experiments enhances target-cell necrosis and inhibits apoptosis, inhibiting wound healing using BAPTA-AM during CTL attack also promotes necrosis. If CMV peptide-coated B cell targets are loaded with BAPTA-AM before initiating attack by CMV-specific CTLs, necrotic cell death, assayed by PI bright staining 1 hr later (before apoptosis has occurred), is significantly enhanced (representative flow cytometry data, Figure 7E ). Although PI bright staining of CTL-exposed target cells incubated with an irrelevant peptide is not changed by BAPTA-AM treatment (8% ± 1% both with and without BAPTA-AM), PI bright cells are increased over background from 27% ± 4% to 35% ± 3% (p < 0.0001) in BAPTA-AM-loaded target cells. Although the difference is small (a 27% increase in necrosis over background), these data were reproduced in two additional independent experiments. Therefore, the wound-healing response in target cells subjected to CTL attack contributes to preventing necrosis, recapitulating our results obtained with sublytic PFN or isolated NK cell granules.
PFN Triggers Rapid Endocytosis of GzmB
Cytotoxic T Lymphocytes Trigger a Ca
Discussion
In this study, we reexamined the effect of native PFN on the target-cell membrane. At sublytic concentrations that do not cause cell death on their own, PFN damages the plasma membrane and induces a transient Ca 2+ flux, which triggers a cellular repair response, reminiscent of the cellular wound-healing response that reseals holes in injured cell membranes using pieces of membranes donated by intracellular organelles. Cells treated with sublytic PFN take up small amounts of fluid phase dyes, suggesting that at least small pores are formed at the plasma membrane. These pores probably cause an influx of Ca 2+ from the Ca (Froelich et al., 1996) , this process is inefficient and unlikely to be physiologically relevant during CTL attack when PFN-mediated delivery is completed within a few minutes. A recent study using cells expressing dominant-negative mutant dynamin suggests that dynamin-dependent endocytosis is required to trigger GzmB-and PFN-mediated apoptosis (Veugelers et al., 2004). We confirmed this finding (D.K., L.S., S.F., F.N., R.M., T.K., and J.L., unpublished data). However, another study that looked only at cell death did not find dynamin to be important (Trapani et al., 2003) . One way to reconcile these seemingly contradictory data would be if dynamin were not required for necrotic death by PFN since it involves direct plasma membrane damage, while dynamin-dependent endocytosis is needed for PFN to deliver Gzms to activate apoptosis. Because the difference between lytic and sublytic PFN concentration is so small and the activity of stored PFN is not very stable, special care is required in doing experiments with PFN to distinguish between its necrotic and Gzm delivery functions.
The membrane-repair response may not be responsible for the rapid PFN-mediated endocytosis of Gzms, since ionomycin, another stimulus for the repair response, does not enhance GzmB internalization. However, because ionomycin persists in treated cells, causing sustained increases in intracellular Ca 2+ , while generally after PFN treatment or membrane resealing the Ca 2+ flux is transient, this question needs to be examined using other initiators of membrane damage. The molecular basis for PFN-mediated delivery of Gzms into the large endocytic vesicles and from there to the cytosol still needs to be understood. This study suggests that although both the original pore model and the revised pore-independent endosomolysis model for PFN action may be correct in certain respects, neither fully explains all of the data. Our revised model, which incorporates some features of both models, is consistent with the known data.
The target cell is therefore an active participant in its own death. The membrane-repair response allows the target to restore membrane integrity, avoid necrosis, and undergo apoptosis. Because apoptotic, but not necrotic, cells are rapidly phagocytosed, target-cell membrane repair should reduce inflammation caused by necrotic cells. This should help maintain immune specificity, eliminating the intended target cell without causing harm to bystander cells.
Experimental Procedures
Cell Lines and Reagents U937 cells were grown in cell-culture medium (RPMI 1640 supplemented with 10% FCS, 2 mM glutamine, 2 mM HEPES, 100 U/ml penicillin, 100 mg/ml streptomycin, and 50 M β-mercaptoethanol). HeLa cells were grown to roughly 60% confluency in DMEM, supplemented as above, on collagen-coated BIOCOAT slides (BD Labware, Beverly, MA). CTLs were generated from human PBMCs treated with 2 g/ml PHA and cultured for 7-20 days in cell-culture medium containing 600 IU/ml recombinant human IL-2 (a kind gift of Chiron Oncology). In some experiments, CMV peptide-specific CTL, generated as described (Martinvalet et al., 2005) , was used to lyse autologous EBV-transformed B cells, pulsed with specific CMV peptide or control peptide. Cytotoxic granules, GzmB, and PFN were purified from rat NK cells as described (Shi et al., 2000) . Recombinant GzmB was purified from baculovirus as reported (Xia et al., 1998) . Rabbit anti-GzmB was produced in the laboratory of the late A. Greenberg (University of Winnipeg) and has been described (Shi et al., 2000) . Mouse Lamp-1 mAb was from Developmental Studies Hybridoma Bank (University of Iowa); goat anti-EEA-1 was from Santa Cruz; rabbit anti-calreticulin was from Stressgen Biotechnology; Cy5-conjugated anti-CD8 was from Caltag; and anti-CD3 was purified from the OKT3 hybridoma. ConA and PI were from Sigma. AlexaFluor 488 (Molecular Probes) was used to label recombinant GzmB using the manufacturer's protocol. Sytox green, DiI, FITC-dextran, BAPTA-AM, fluo-3-AM, fura-2-AM, DDAO-SE, Alexa-488 conjugated transferrin, and Alexa-conjugated secondary antibodies were from Molecular Probes.
PFN and GzmB Loading
Cells were equilibrated in cell-loading buffer (HBSS with 10 mM HEPES, 2 mM CaCl 2 , 0.4% BSA). PFN and/or GzmB were added simultaneously at the indicated doses for the indicated times. The sublytic PFN dose was determined independently for each cell line, PFN preparation and experiment, as the concentration required to induce 5%-15% trypan blue or PI uptake (Shi et al., 1992) . PI (final concentration, 2 g/ml) was added during or after PFN incubation where indicated. For apoptosis assays, cells were incubated for 4 hr at 37°C. For GzmB-488 uptake assays, U937 or HeLa cells were incubated for the indicated times with GzmB-488 (30 g/ml) in the presence of cell-loading buffer alone, 10 M ionomycin, or PFN (0.1 g/ml or indicated concentrations for U937; 0.4 g/ml for HeLa). U937 cells were washed in 1 mM 5 kDa dextran sulfate to remove surface bound GzmB before flow cytometry as described (Shi et al., 2005) .
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